Gulf Pharm Ind (JULPHAR)

Currency in AED
1.050
0.000(0.00%)
Closed·
JULPHAR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.0501.070
52 wk Range
0.9561.610
Key Statistics
Bid/Ask
1.40 / 1.42
Prev. Close
1.33
Open
1.06
Day's Range
1.05-1.07
52 wk Range
0.956-1.61
Volume
1.57M
Average Volume (3m)
1.46M
1-Year Change
-23.3577%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JULPHAR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.080
Upside
+2.86%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Gulf Pharm Ind News & Analysis

Show more

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.080
(+2.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 27, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
279.4M / --
EPS Revisions
Last 90 days

JULPHAR Income Statement

Compare JULPHAR to Peers and Sector

Metrics to compare
JULPHAR
Peers
Sector
Relationship
P/E Ratio
28.3x6.3x−0.5x
PEG Ratio
0.100.140.00
Price/Book
1.3x4.4x2.6x
Price / LTM Sales
1.1x2.3x3.2x
Upside (Analyst Target)
2.9%37.6%50.8%
Fair Value Upside
Unlock13.5%7.7%Unlock

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract. The company is also involved in transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; agent; sale of cosmetics; export and import activities; and trading in medical equipment. Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.

Employees
2400

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.01M0.35%4.21M
Other Institutional Investors
491.20M42.52%515.76M
Public Companies & Retail Investors
660.01M57.13%693.01M
Total
1.16B100.00%1.21B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.14%1,623,0751,704
Dimensional ETF Trust - Dimensional Emerging Markets Core Equity 2 ETF0.05%559,766588

FAQ

What Is the Gulf Pharm Ind (JULPHAR) Stock Price Today?

The Gulf Pharm Ind stock price today is 1.050 AED.

What Stock Exchange Does Gulf Pharm Ind Trade On?

Gulf Pharm Ind is listed and trades on the Abu Dhabi.

What Is the Stock Symbol for Gulf Pharm Ind?

The stock symbol for Gulf Pharm Ind is "JULPHAR."

What Is the Gulf Pharm Ind Market Cap?

As of today, Gulf Pharm Ind market cap is 1.200B AED.

What Is Gulf Pharm Ind's Earnings Per Share (TTM)?

The Gulf Pharm Ind EPS (TTM) is 0.037.

When Is the Next Gulf Pharm Ind Earnings Date?

Gulf Pharm Ind will release its next earnings report on May 19, 2026.

From a Technical Analysis Perspective, Is JULPHAR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Gulf Pharm Ind Stock Split?

Gulf Pharm Ind has split 15 times.

How Many Employees Does Gulf Pharm Ind Have?

Gulf Pharm Ind has 2400 employees.

What is the current trading status of Gulf Pharm Ind (JULPHAR)?

As of Apr 30, 2026, Gulf Pharm Ind (JULPHAR) is trading at a price of 1.050 AED, with a previous close of 1.330 AED. The stock has fluctuated within a day range of 1.050 AED to 1.070 AED, while its 52-week range spans from 0.956 AED to 1.610 AED.

What Is Gulf Pharm Ind (JULPHAR) Price Target According to Analysts?

The average 12-month price target for Gulf Pharm Ind is 1.080 AED, with a high estimate of 1.08 AED and a low estimate of 1.08 AED. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +2.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.